Treatment of Colorectal Liver Metastasis and Carcinomatosis and the Role of HIPEC

As a result of participating in this activity, learners will be able to: Discuss the role of Combined Modality Therapy for treatment of colorectal Liver metastasis, identify the sequence of Combined Modality Therapy in Liver Metastasis from Rectal cancer, and review indications and Contraindications for HIPEC in Colorectal Carcinomatosis.

 

The target audience for this presentation: Currently practicing physicians who actively see patients in Oncology, Radiation Oncology, Gastroenterology, and Family Medicine.

 

This activity has been approved for AMA PRA Category 1 Credit™

 

View related document for accreditation information.

 

CONTACT

If you have any questions or credit related inquiries, please contact USF Health at cpdsupport@usf.edu


Published

June 23, 2020

Created by

Tampa General Hospital

Presenters

Andreas Karachristos, FACS, MD, PhD

Andreas Karachristos, FACS, MD, PhD

Chief of Surgical Oncology
Hepatobiliary and Pancreatic Surgery
Professor of Surgery
Department of Surgery
University of South Florida

Dr. Andreas Karachristos specializes in hepato-pancreato-biliary(HPB) or the care of the liver, pancreas, bile duct and gallbladder. 

J. Ryan Williams, MD

J. Ryan Williams, MD

Assistant Professor
Division of Colon and Rectal Surgery
University of South Florida
Morsani College of Medicine

Assistant Professor at USF Health Morsani College of Medicine for the Division of Colon & Rectal Surgery